Log in

Hvivo Stock Price, News & Analysis (LON:HVO)

GBX 16
-0.25 (-1.54 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
15.50
Now: GBX 16
15.90
50-Day Range
15.75
MA: GBX 17.56
19.50
52-Week Range
13.20
Now: GBX 16
55
Volume34,981 shs
Average Volume49 shs
Market Capitalization£13.32 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
hVIVO plc, a specialty biopharma company, provides medical and scientific research services in the United Kingdom, the United States, and Europe. The company is developing a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases, including influenza virus, respiratory syncytial virus, asthma exacerbation, and human rhinovirus. It also offers laboratory based research services; and target and biomarker discovery services. hVIVO plc primarily serves pharmaceutical and biotech customers. The company was formerly known as Retroscreen Virology Group plc and changed its name to hVIVO plc in April 2015. hVIVO plc was incorporated in 1988 and is based in London, the United Kingdom.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-77561300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£12.09 million
Cash FlowGBX 4.75 per share
Book ValueGBX 16.50 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£13.32 million
Next Earnings DateN/A
OptionableNot Optionable

Receive HVO News and Ratings via Email

Sign-up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter.


Hvivo (LON:HVO) Frequently Asked Questions

What is Hvivo's stock symbol?

Hvivo trades on the London Stock Exchange (LON) under the ticker symbol "HVO."

How were Hvivo's earnings last quarter?

Hvivo PLC (LON:HVO) posted its quarterly earnings data on Thursday, April, 19th. The company reported ($16.50) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($10.90) by $5.60. View Hvivo's Earnings History.

Has Hvivo been receiving favorable news coverage?

Headlines about HVO stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Hvivo earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Hvivo.

Who are some of Hvivo's key competitors?

What other stocks do shareholders of Hvivo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hvivo investors own include ValiRx (VAL), Boohoo Group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Solo Oil (SOLO), Cyanconnode (CYAN), Eckoh (ECK), Lloyds Banking Group (LLOY) and Enanta Pharmaceuticals (ENTA).

Who are Hvivo's key executives?

Hvivo's management team includes the folowing people:
  • Mr. Graham Edward Yeatman, Chief Financial & Bus. Officer and Company Sec. (Age 52)
  • Mr. David Robert Norwood, Strategic Consultant (Age 50)
  • Dr. Trevor Michael Phillips, Exec. Chairman & CEO (Age 58)
  • Ms. Fleur Wood, Exec. VP of Investor Relations & Communications
  • Colin Paterson, Director of Marketing, Communication & PR

How do I buy shares of Hvivo?

Shares of HVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Hvivo's stock price today?

One share of HVO stock can currently be purchased for approximately GBX 16.

How big of a company is Hvivo?

Hvivo has a market capitalization of £13.32 million and generates £12.09 million in revenue each year. View Additional Information About Hvivo.

What is Hvivo's official website?

The official website for Hvivo is http://hvivo.com/.

How can I contact Hvivo?

Hvivo's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The company can be reached via phone at +44-20-77561300.


MarketBeat Community Rating for Hvivo (LON HVO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  214
MarketBeat's community ratings are surveys of what our community members think about Hvivo and other stocks. Vote "Outperform" if you believe HVO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HVO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel